Andrew Joy


After an early career at Hill Samuel in banking and corporate finance, Andrew has been involved full-time in private equity since 1984.  In that time he has led and served on the Board as director or chairman of numerous companies.  He has also been responsible both at Cinven, where he was a partner for over 20 years, and predecessor firms for fund-raising.

In 1995-96 he was Chairman of the British Venture Capital Association and until 2013 was a director of the European equivalent.  Andrew is a Director of The Biotech Growth Trust plc, a senior advisor to Cinven and Stonehage Fleming and is involved in a number of not-for-profit organisations.